# NALOXEGOL
> **ANDA212625** · Abbreviated New Drug Application (Generic) · Sponsor: MSN LABS PVT LTD · Approved 2021-02-24
## Drug
- **FDA Application Number:** ANDA212625
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NALOXEGOL
- **Generic name:** Naloxegol
- **Active ingredients:** NALOXEGOL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MSN LABS PVT LTD
- **First approval:** 2021-02-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212625)
---
*MORVS · CC0 1.0*